263 related articles for article (PubMed ID: 17065350)
41. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
[TBL] [Abstract][Full Text] [Related]
42. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
[TBL] [Abstract][Full Text] [Related]
43. Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist.
Sen S; Chen S; Feng B; Iglarz M; Chakrabarti S
Life Sci; 2012 Oct; 91(13-14):658-68. PubMed ID: 22525377
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters.
Maeda Y; Inoguchi T; Takei R; Sawada F; Sasaki S; Fujii M; Kobayashi K; Urata H; Nishiyama A; Takayanagi R
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1328-38. PubMed ID: 20881036
[TBL] [Abstract][Full Text] [Related]
46. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
Nakagawa T; Yokozawa T; Yamabe N; Rhyn DY; Goto H; Shimada Y; Shibahara N
J Pharm Pharmacol; 2005 Sep; 57(9):1205-12. PubMed ID: 16105242
[TBL] [Abstract][Full Text] [Related]
47. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
Cameron NE; Cotter MA
Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
[TBL] [Abstract][Full Text] [Related]
48. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.
Widyantoro B; Emoto N; Nakayama K; Anggrahini DW; Adiarto S; Iwasa N; Yagi K; Miyagawa K; Rikitake Y; Suzuki T; Kisanuki YY; Yanagisawa M; Hirata K
Circulation; 2010 Jun; 121(22):2407-18. PubMed ID: 20497976
[TBL] [Abstract][Full Text] [Related]
49. Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
Rodriguez WE; Tyagi N; Joshua IG; Passmore JC; Fleming JT; Falcone JC; Tyagi SC
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F694-701. PubMed ID: 16609149
[TBL] [Abstract][Full Text] [Related]
50. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
51. Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.
Menne J; Shushakova N; Bartels J; Kiyan Y; Laudeley R; Haller H; Park JK; Meier M
Diabetes; 2013 Apr; 62(4):1167-74. PubMed ID: 23434935
[TBL] [Abstract][Full Text] [Related]
52. Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice.
Ouyang X; Le TH; Roncal C; Gersch C; Herrera-Acosta J; Rodriguez-Iturbe B; Coffman TM; Johnson RJ; Mu W
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F902-10. PubMed ID: 15928210
[TBL] [Abstract][Full Text] [Related]
53. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
[TBL] [Abstract][Full Text] [Related]
54. Effect of telmisartan on expression of protein kinase C-alpha in kidneys of diabetic mice.
Yao LJ; Wang JQ; Zhao H; Liu JS; Deng AG
Acta Pharmacol Sin; 2007 Jun; 28(6):829-38. PubMed ID: 17506942
[TBL] [Abstract][Full Text] [Related]
55. ACE and ACE2 activity in diabetic mice.
Wysocki J; Ye M; Soler MJ; Gurley SB; Xiao HD; Bernstein KE; Coffman TM; Chen S; Batlle D
Diabetes; 2006 Jul; 55(7):2132-9. PubMed ID: 16804085
[TBL] [Abstract][Full Text] [Related]
56. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
57. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause.
Keck M; Romero-Aleshire MJ; Cai Q; Hoyer PB; Brooks HL
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F193-9. PubMed ID: 17389681
[TBL] [Abstract][Full Text] [Related]
58. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.
Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M
Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952
[TBL] [Abstract][Full Text] [Related]
59. [Effect of Tujian decoction on protein kinase C activity in renal cortex in diabetic rat].
Piao YL; Liang XC; Yang N; Yin DH; Zuo PP
Zhongguo Zhong Yao Za Zhi; 2004 Jul; 29(7):685-9. PubMed ID: 15503781
[TBL] [Abstract][Full Text] [Related]
60. High-molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice.
Campo GM; Avenoso A; Micali A; Nastasi G; Squadrito F; Altavilla D; Bitto A; Polito F; Rinaldi MG; Calatroni A; D'Ascola A; Campo S
Biochim Biophys Acta; 2010 Nov; 1802(11):1118-30. PubMed ID: 20713153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
